Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

Abstract A pathogen inactivation step during collection or processing of clinical samples has the potential to reduce infectious risks associated with diagnostic procedures. It is essential that these inactivation methods are demonstrated to be effective, particularly for non-traditional inactivatio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katherine Davies, Ulrike Arnold, Hubert Buczkowski, Christopher Burton, Stephen R. Welch, Nicole Green, Rhea Strachan, Tracy Beetar-King, Peter Spencer, Nipunadi Hettiarachchi, Matthew J. Hannah, Matthew Jones, Patricia A. Cane, Christine B. Bruce, Neil Woodford, Allen D. G. Roberts, Marian J. Killip
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/3e64d64e5ccb421ebe31842603e18bbf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/3e64d64e5ccb421ebe31842603e18bbf

Ejemplares similares